Alvotech
ALVO ALVOWCIK 0001898416 · Biological Products, (No Diagnostic Substances) · Nasdaq, Nasdaq
- Alvotech Lux Holdings S.A.S. (until 2022-05-02)
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
$27.92M
+112.0% YoY
FY Dec 2025
EPS Diluted (TTM)
$0.10
+111.5% YoY
FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$172.36M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
312.02M sh
FY Dec 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.